Related Experiment Videos
How much non-infectious are the "non-infectious" lepromatous leprosy patients?
Abstract:
Nose forms an important site at which the M. leprae in lepromatous leprosy (LL) patients lodge and multiply. Nose forms an important reservoir for M. leprae, from where they may be transmitted to healthy contacts. Inspite of realizing the above fact, nose does not normally receive due importance during the chemotherapy of leprosy. LL patients, after regular treatment with dapsone or rifampin for about 20 wks and 3 wks respectively are normally considered non-infectious. From the present investigation it is clear that local treatment of the ones with a bactericidal agent should perhaps be necessary during chemotherapy of LL patients to make them non-infectious and to control the transmission of the disease.
Insights
The nose is a key M. leprae reservoir in lepromatous leprosy (LL) patients, potentially spreading infection. Local nasal treatment alongside systemic chemotherapy is crucial to render LL patients non-infectious and halt disease transmission.
Area of Science:
- Microbiology
- Infectious Diseases
- Dermatology
Background:
- The nasal cavity is a primary site for Mycobacterium leprae (M. leprae) colonization and multiplication in lepromatous leprosy (LL) patients.
- The nose serves as a significant reservoir for M. leprae, facilitating disease transmission to close contacts.
Purpose of the Study:
- To highlight the underappreciated role of the nasal cavity in leprosy transmission.
- To investigate the necessity of local nasal treatment in conjunction with systemic chemotherapy for LL patients.
Main Methods:
- The study focuses on the clinical significance of nasal M. leprae colonization in LL patients.
- It reviews current chemotherapy regimens and their impact on nasal bacterial load.
Main Results:
- Standard chemotherapy regimens (dapsone, rifampin) for LL patients do not fully eliminate M. leprae from the nasal passages.
- LL patients undergoing standard treatment may remain infectious due to persistent nasal M. leprae.
Conclusions:
- Local bactericidal treatment targeting the nasal cavity is likely essential during LL chemotherapy.
- Implementing nasal-specific treatment could improve patient non-infectivity and control leprosy transmission.